Clinical Trials Browser

Phase EARLY_PHASE1 × Carcinoma × 90 days × Clear all

NCT05065736 2026-03-19

Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

Phase EARLY_PHASE1 Recruiting

Adenocarcinoma, Carcinoma, Neoplasm Metastasis, Neoplasms